Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Intradermal vs. Intramuscular Delivery of Influenza Vaccine in Immunocompetent Elders.

Trial Profile

Intradermal vs. Intramuscular Delivery of Influenza Vaccine in Immunocompetent Elders.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 May 2014

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 12 Jul 2012 Actual patient number changed from 300 to 257 as reported by ClinicalTrials.gov.
    • 08 Apr 2010 Results published in Clinical Infectious Diseases.
    • 30 Apr 2008 Preliminary results were reported at AGS 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top